Uterine Fibroids
📧 Sign up to get email alerts when something new happens for Uterine Fibroids.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-08-13Clinical Trial Update: Does Preventive Uterine Artery Occlusion During Laparoscopic Myomectomy Impact on Ovarian Reserve Markers? [NA]
A completed clinical trial evaluating whether preventive uterine artery occlusion during laparoscopic myomectomy influences markers of ovari…
-
CLINICAL_TRIALS research · 2024-08-09Clinical Trial Update: Binaural Sound for Remimazolam Maintenance [NA]
A clinical trial update shows recruitment for a study evaluating binaural sound during remimazolam maintenance anesthesia. The study include…
-
CLINICAL_TRIALS trial_result · 2024-07-30Clinical Trial Update: HYALOBARRIER® GEL ENDO Versus no HYALOBARRIER® GEL ENDO Following Operative Hysteroscopy for Improving Reproductive Outcome in Women With Intrauterine Pathology Wishing to Become Pregnant [NA]
A clinical trial comparing HYALOBARRIER GEL ENDO to no gel after operative hysteroscopy to improve reproductive outcomes in women with intra…
-
CLINICAL_TRIALS trial_result · 2024-07-29Clinical Trial Update: Virtual Reality's Role in See&Treat Hysteroscopy [NA]
A completed clinical trial from Federico II University evaluated the use of virtual reality-assisted see-and-treat hysteroscopy for endometr…
-
CLINICAL_TRIALS trial_result · 2024-07-10Clinical Trial Update: Diffusion -and Perfusion Weighted MRI for Response Prediction of Symptomatic Leiomyomas Following Uterine Artery Embolization [NA]
This clinical trial evaluates whether diffusion- and perfusion-weighted MRI can predict response after uterine artery embolization in women …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-07-09Clinical Trial Update: Single Arm Study Using the Symphony -- MRI Guided Focused Ultrasound System for the Treatment of Leiomyomas [NA]
Completed results from a single-arm clinical trial evaluating the Symphony MRI-guided focused ultrasound system for treating uterine fibroid…
-
CLINICAL_TRIALS research · 2024-07-03Clinical Trial Update: Ultrasound Evaluation of the Myometrium Using the MUSA Terminology Comparison With Histology
This study evaluates ultrasound of the myometrium using the MUSA terminology and compares imaging findings to histology to help standardize …
-
CLINICAL_TRIALS trial_result · 2024-06-25Clinical Trial Update: Study of Relugolix With Estradiol and Norethindrone Acetate in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids [Phase 3]
Phase 3 study evaluating Relugolix with estradiol and norethindrone acetate for heavy menstrual bleeding due to uterine fibroids has complet…
-
CLINICAL_TRIALS research · 2024-06-25Clinical Trial Update: The Effect of Intramyometrial Injection of Terlipressin Versus Intramyometrial Injection of Carbitocin on Hemoglobin and Blood Loss During Laparoscopic Myomectomy Operations [NA]
Clinical trial update comparing intramyometrial terlipressin versus intramyometrial carbetocin on hemoglobin levels and blood loss during la…
-
CLINICAL_TRIALS trial_result · 2024-06-25Clinical Trial Update: The Effect of Intramyometrial Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Open Myomectomy Operations Using Haemostatic Tourniquets: [NA]
Completed trial comparing intramyometrial terlipressin versus carbetocin on hemoglobin and blood loss during open myomectomy using haemostat…
-
CLINICAL_TRIALS research · 2024-06-25Clinical Trial Update: The Effect of Intracapsular Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Laparoscopic Myomectomy Operations [NA]
This clinical trial compares intracapsular injection of terlipressin versus carbetocin to assess effects on hemoglobin and blood loss during…
-
CLINICAL_TRIALS withdrawal · 2024-05-30Clinical Trial Update: Evaluating Tibolone Add-back in Patients With Endometriosis and Fibroids
A clinical trial evaluating tibolone add-back in patients with endometriosis and uterine fibroids has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2024-05-09Clinical Trial Update: LIBERTY EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids [Phase 3]
Results from the LIBERTY EXTENSION, a Phase 3 extension study of relugolix in women with heavy menstrual bleeding due to uterine fibroids, e…
-
FDA approval · 2024-04-30FDA Approved: MYFEMBREE — Supplemental Application (Sumitomo Pharma America, Inc)
FDA approved a supplemental application for MYFEMBREE, a relugolix/estradiol hemihydrate/norethindrone acetate combination, expanding its la…
-
CLINICAL_TRIALS trial_result · 2024-03-22Clinical Trial Update: Misoprostol Versus Oxytocin Infusion On Reducing Blood Loss During Abdominal Myomectomy [Phase 3]
Phase 3 trial comparing misoprostol vs oxytocin infusion for reducing blood loss during abdominal myomectomy.
-
CLINICAL_TRIALS trial_result · 2024-01-24Clinical Trial Update: A Phase II/III Study of Efficacy and Safety of SHR7280 Tablets in Subjects With Menorrhagia With Uterine Fibroids [Phase 2, Phase 3]
Phase II/III clinical trial evaluating SHR7280 tablets for efficacy and safety in menorrhagia due to uterine fibroids; recruiting patients.
-
FDA label_change · 2024-01-23FDA Approved: VABRINTY — Supplemental Application (URONOVA PHARMACEUTICALS, INC.)
FDA approved a supplemental application for VABRINTY (leuprolide acetate) from Uronova Pharmaceuticals to modify the drug's labeling.
-
CLINICAL_TRIALS trial_result · 2024-01-09Clinical Trial Update: Combined Vaginal Misoprostol and Perivascular Vasopressin [Phase 4]
A Phase 4 clinical trial evaluating combined vaginal misoprostol and perivascular vasopressin for uterine fibroid-related procedures; study …
-
FDA approval · 2023-12-04FDA Approved: LUPRON DEPOT — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for LUPRON DEPOT (leuprolide acetate) from AbbVie, updating the product's label under a supplemental…
-
CLINICAL_TRIALS withdrawal · 2023-10-24Clinical Trial Update: Safety Trial of Magnetic Resonance (MR) Guided Focused Ultrasound Surgery (FUS) in Women With Uterine Fibroids Wishing to Pursue Pregnancy in the Future [Phase 4]
A Phase 4 safety trial of MR-guided focused ultrasound for uterine fibroids in women desiring future pregnancy has been withdrawn.
-
FDA approval · 2023-06-05FDA Approved: ORIAHNN — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for Oriahnn (elagolix, estradiol, and norethisterone) from AbbVie. This action confirms the regulato…
-
CLINICAL_TRIALS trial_result · 2023-06-05Clinical Trial Update: Pharmacokinetics and Hepatic Safety of EGCG [Phase 1]
Phase 1 study evaluating pharmacokinetics and hepatic safety of EGCG in uterine fibroids; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2023-04-10Clinical Trial Update: Methods Decreasing Bleeding in Open Myomectomy [Phase 4]
A Phase 4 clinical trial update focuses on methods to decrease bleeding during open myomectomy for myoma, exploring strategies in patients w…
-
CLINICAL_TRIALS trial_result · 2023-03-21Clinical Trial Update: Efficacy and Safety of BG2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids. [Phase 3]
Phase 3 trial update for BG2109 evaluating efficacy and safety in heavy menstrual bleeding associated with uterine fibroids.
-
CLINICAL_TRIALS trial_result · 2023-03-09Clinical Trial Update: Preoperative Vaginal Dinoprostone Versus Misoprostone in Abdominal Myomectomy [Phase 3]
Phase 3 trial comparing preoperative vaginal dinoprostone with misoprostol in abdominal myomectomy has completed.